Plozasiran
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Correction to 'Clinical Trial: Plozasiran Prevents Recurrent Pancreatitis in Adults With Very Severe Hypertriglyceridemia-Results of a Post Hoc Analysis of the Phase 3 PALISADE Study'.
Journal: Alimentary pharmacology & therapeutics
Published: June 13, 2026
ApoC[III] You Later: A Review of Plozasiran for the Management of Familial Chylomicronemia Syndrome.
ApoC[III] You Later: A Review of Plozasiran for the Management of Familial Chylomicronemia Syndrome.
Journal: The Annals of pharmacotherapy
Published: June 06, 2026
Translating Lipoprotein Genetics Into New Therapies.
Journal: Circulation research
Published: June 04, 2026
Letter: Plozasiran for Recurrent Pancreatitis and the Chinese Burden of Hypertriglyceridaemic Acute Pancreatitis.
Journal: Alimentary pharmacology & therapeutics
Published: May 21, 2026
Evolution of siRNA Therapeutics: From Mechanistic Foundations to Clinical Expansion.
Journal: Pharmaceutics
Published: April 16, 2026
Plozasiran (Redemplo) for familial chylomicronemia syndrome.
Journal: The Medical letter on drugs and therapeutics
Published: April 10, 2026
The Approval of Redemplo for Familial Chylomicronemia Syndrome and the Many Flavors of GalNAc-Oligonucleotides.
Journal: Nucleic acid therapeutics
Published: March 25, 2026
The evaluation of plozasiran for the treatment of familial chylomicronemia syndrome.
Journal: Expert review of endocrinology & metabolism
Published: March 20, 2026
RNA interference for lipid disorders: is this the future?
Journal: Current opinion in lipidology
Published: February 28, 2026
Current and Emerging Pharmacological Therapies for Hypertriglyceridemia.
Journal: International journal of molecular sciences
Published: February 28, 2026
Comparative efficacy and safety of olezarsen vs plozasiran for familial chylomicronemia syndrome: A matching-adjusted indirect comparison.
Journal: Journal of clinical lipidology
Published: February 17, 2026
Last Updated: 06/30/2026